Korea's Green Cross Strengthens Vaccine Supply Chain For Growing Export Demand
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's leading vaccine producer Green Cross has opened and begun operation of a vaccine egg farm to build up a stable channel for the supply of flu vaccine eggs to the pharma's vaccine plant in Hwasoon, Southwest of Seoul. The company is preparing for increased domestic competition, but it also benefiting from a pickup in foreign demand
You may also be interested in...
Green Cross Is Latest Korean Pharma To Struggle Under Regulatory Headwinds
SEOUL - Green Cross Corp. has continued a trend among Korean pharma companies by posting relatively sluggish second quarter results
Green Cross Is Latest Korean Pharma To Struggle Under Regulatory Headwinds
SEOUL - Green Cross Corp. has continued a trend among Korean pharma companies by posting relatively sluggish second quarter results
Green Cross Banking On Bioreactors To Develop Biosimilars, Biobetters Faster
SEOUL - Following a deal late last year to jointly develop biopharmaceutical products through disposable bioreactors, South Korea's vaccine giant Green Cross Corp. is expanding its collaboration to sell PBS Biotech, Inc.'s bioreactors to Korean companies